JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H. D.
Right arrow Articles by Shukla, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H. D.
Right arrow Articles by Shukla, S. D.

Glucose transport in human platelets and its inhibition by forskolin

HD Kim, S Sergeant and SD Shukla

Hexose transport in washed human platelets and its inhibition by forskolin was examined by using 3-O-methylglucose (MG). MG influx in platelets exhibited saturable kinetics with the Km of 1.74 mM and the Vmax of 0.242 mumol/ml of cells X sec at 20 degrees C. Forskolin was found to reduce the Vmax without appreciably affecting the Km, suggesting a noncompetitive mode of inhibition. Forskolin inhibited MG influx with an IC50 value of approximately 2 microM. Forskolin also inhibited the influx of other carbohydrates, including galactose, fructose and ribose. However, forskolin had no effect on adenosine transport. MG transport was abolished instantaneously by forskolin before a significant increase in cellular cyclic AMP content. While both forskolin and prostaglandin l2 stimulated cyclic AMP formation severalfold, only forskolin inhibited MG influx. These findings suggest that the inhibitory action of forskolin on MG transport is unrelated to its well established ability to activate adenylate cyclase and that human platelets possess a hexose transport which is unresponsive to cyclic AMP.

Volume 236, Issue 3, pp. 585-589, 03/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Li, V. Woo, and R. Bose
Platelet hyperactivity and abnormal Ca2+ homeostasis in diabetes mellitus
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1480 - H1489.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. Waite, R. Wallin, D. Qualliotine-Mann, and L. C. McPhail
Phosphatidic Acid-mediated Phosphorylation of the NADPH Oxidase Component p47-phox. EVIDENCE THAT PHOSPHATIDIC ACID MAY ACTIVATE A NOVEL PROTEIN KINASE
J. Biol. Chem., June 13, 1997; 272(24): 15569 - 15578.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Khanum, E. Buczko, and M. L. Dufau
Essential Role of Adenosine Triphosphate in Activation of 17{beta}-Hydroxysteroid Dehydrogenase in the Rat Leydig Cell
Endocrinology, April 1, 1997; 138(4): 1612 - 1620.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics.